Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pregnancy Test Provides Additional Format

By LabMedica International staff writers
Posted on 13 Sep 2010
A urine dipstick test for the qualitative detection of human Chorionic Gonadotropin (hCG) has received 510(k) clearance.

The lateral flow pregnancy immunoassay has the ability to detect low hCG levels as early as 2-3 days before expected menses with a sensitivity of 25 mIU/mL. More...
The test is very rapid giving results in three minutes.

The RapidVue hCG test is easy-to-interpret the results with a two-color endpoint that needs no special training to interpret. The kit has a long shelf life: up to 12 months from the date of manufacture, so small volume users need not worry that product will expire before used. Each test is individually foil wrapped for freshness in the 25-test kit. The manufacturers claim the test is >99% accurate.

The RapidVue hCG test is manufactured by Quidel Corporation (San Diego, CA, USA). The test has been cleared (510k) by the US Food and Drug Administration (FDA, Silver Spring, MD, USA) as a pregnancy test. The 3-minute RapidVue hCG test is Clinical Laboratory Improvement Amendments (CLIA)-waived for use with urine samples. Due to the assay's dipstick format, RapidVue hCG requires no specimen manipulation in order to perform the test.

Douglas C. Bryant, president and CEO of Quidel Corporation, said, "Our customers have expressed a preference for testing flexibility and our new RapidVue hCG product provides healthcare professionals with an additional format for pregnancy testing". RapidVue hCG is Quidel's fourth product launch in the United States this year and is further confirmation of their success at reinvigorating their new product pipeline.

Related Links:

Quidel Corporation
FDA



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.